Inactivation of nontuberculous mycobacteria by gaseous ozone treatment

Elsevier

Available online 8 March 2023

Journal of Infection and ChemotherapyAuthor links open overlay panel, , , Abstract

Nontuberculous mycobacteria (NTM) are environmental bacteria resistant to many common disinfectants and ultraviolet radiation. Inhalation of aerosols generated from NTM-containing water and soil causes NTM lung disease, especially in people with underlying lung diseases and decreased immunity. To prevent healthcare-acquired NTM infections, it is important to eradicate NTM living in hospital environments. Therefore, we evaluated the efficacy of gaseous ozone for the inactivation of NTM, namely Mycobacterium (M.) avium, M. intracellulare, M. kansasii, M. abscessus and M. massiliense. Gaseous ozone treatment at 1 ppm for 3 h reduced the bacterial number of all strains by more than 97%. Gaseous ozone treatment could be a practical, effective and convenient disinfection method for NTM living in hospital environments.

Section snippetsAuthorship statement

KM designed the study and did the experiments, and analyzed and interpreted the data. TN designed the study, and analyzed and interpreted the data. SK did the experiments and interpreted the data. NH designed the study and interpreted the data. All authors contributed to the writing of the final manuscript. All authors meet the ICMJE authorship criteria.

Funding statement

Dream Medical Partners Co., Ltd. provided funding for the research. However, the sponsor had no role in the execution, interpretation, or writing of the study.

Declaration of competing interest

This study was completed as part of our collaborative research with Dream Medical Partners Co., Ltd. (Chiyoda-ku, Tokyo, Japan).

Acknowledgements

We thank Tamura TECO Co., Ltd. (Higashiosaka-shi, Osaka, Japan) for technical assistance.

References (10)

There are more references available in the full text version of this article.

View full text

© 2023 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

留言 (0)

沒有登入
gif